XML 29 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
OPERATING ACTIVITIES:      
Net (loss) income $ (200,649) $ 505,680 $ (190,147)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:      
Depreciation and amortization 256,494 103,375 124,629
Impairments and other losses (gains), net 121,473 (224,831) (3,045)
Amortization of debt discount and deferred financing costs 3,181 5,063 8,728
Amortization of deferred production content 20,427 0 0
Deferred income tax (benefit) expense (132,540) 123,467 (31,270)
Share-based compensation expense 48,010 62,658 77,141
Net unrealized and realized loss (gains) on equity investments with readily determinable fair value and loss (earnings) in nonconsolidated affiliates 22,971 (548,690) 54,869
Loss on extinguishment of debt 0 0 35,815
Other non-cash adjustments 486 (538) 1,450
Change in assets and liabilities, net of dispositions:      
Accounts receivable, net (115,096) 7,103 (30,749)
Related party payables, net (31,218)    
Related party receivables, net   35,811 14,778
Prepaid expenses and other current and non-current assets (50,610) (178,758) (43,982)
Accounts payable, accrued and other current and non-current liabilities (28,056) 117,278 78,442
Deferred revenue 61,515 135,448 18,572
Right-of-use lease assets and operating lease liabilities 3,954 10,525 26,109
Net cash (used in) provided by operating activities (19,658) 153,591 141,340
INVESTING ACTIVITIES:      
Proceeds from sale of MSGE Retained Interest 256,501 204,676 0
Capital expenditures, net (264,700) (1,058,978) (756,717)
Capitalized interest (25,053) (116,044) (48,507)
Purchase of business, net of cash acquired (9,424) 0 0
Investments and loans in nonconsolidated affiliates (731) (5,949)  
Investments and loans in nonconsolidated affiliates     1,060
Proceeds from dispositions, net 0 318,003 0
Proceeds from sale of investments 0 4,369 0
Other investing activities (1,776) 0 0
Net cash used in investing activities (45,183) (653,923) (804,164)
FINANCING ACTIVITIES:      
Proceeds from issuance of 3.50% Convertible Senior Notes due 2028 251,634 0 0
Borrowings under Delayed Draw Term Loan Facility 65,000 0 0
Proceeds from exercise of stock options 8,827 0 0
Principal repayments on debt (83,848) (72,875) (725,000)
Taxes paid in lieu of shares issued for share-based compensation (16,543) (16,625) (16,658)
Purchase of capped call related to 3.50% Convertible Senior Notes due 2028 (14,309) 0 0
Payments for debt financing costs (1,030) (5,238) (17,504)
Proceeds from term loans, net of issuance discount 0 302,668 725,000
Noncontrolling interest holders’ capital contributions 0 3,000 6,400
Distribution to MSG Entertainment 0 (119,119) 0
Distribution to related parties associated with the settlement of certain share-based awards 0 (2,388) (2,256)
Repayment of revolving credit facilities 0 (2,000) (15,000)
Distributions to noncontrolling interest holders 0 (1,881) (6,998)
Proceeds from revolving credit facilities 0 0 39,100
Debt extinguishment costs 0 0 (12,838)
Purchase of noncontrolling interest from redeemable noncontrolling interest holders 0 0 (4,638)
Net cash provided by (used in) financing activities 209,731 85,542 (30,392)
Effect of exchange rates on cash, cash equivalents and restricted cash (771) (2,106) (750)
Net increase (decrease) in cash, cash equivalents and restricted cash 144,119 (416,896) (693,966)
Cash, cash equivalents and restricted cash at beginning of period 429,114 846,010 1,539,976
Cash, cash equivalents and restricted cash at end of period 573,233 429,114 846,010
Non-cash investing and financing activities:      
Capital expenditures incurred but not yet paid 49,834 248,041 206,462
Non-cash repayment of the Delayed Draw Term Loan Facility 65,512 0 0
Non-cash forgiveness of Holoplot Loan 9,626 0 0
Share-based compensation capitalized in property and equipment, net 2,193 3,642 2,979
Investments and loans to nonconsolidated affiliates 0 113 791
Continuing Operations      
OPERATING ACTIVITIES:      
Net (loss) income (200,649) 505,680 (190,147)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:      
Depreciation and amortization 256,494 30,716 22,562
Deferred income tax (benefit) expense (132,540) 100,120 (18,348)
FINANCING ACTIVITIES:      
Cash, cash equivalents and restricted cash at beginning of period 429,114 760,312 1,190,105
Cash, cash equivalents and restricted cash at end of period 573,233 429,114 760,312
Discontinued Operations      
FINANCING ACTIVITIES:      
Cash, cash equivalents and restricted cash at beginning of period 0 85,698 349,871
Cash, cash equivalents and restricted cash at end of period $ 0 $ 0 $ 85,698